Carboxylic acid-functionalized SBA-15 nanorods for gemcitabine delivery
Source abstract
Abstract
The present study deals with the functionalization of mesoporous silica nanoparticles as drug delivery systems. Mono, di, and tri amino-functionalized SBA-15 nanorods were synthesized by post-grafting method using (3-aminopropyl) triethoxysilane, N-(2-aminoethyl-)3- aminopropyltrimethoxysilane, and 3-[2-(2-aminoethylamino) ethylamino] propyl trimethoxysilane, respectively. The carboxylic acid derivatives of the amino-functionalized samples were obtained using succinic anhydride. Tminopropyltrimethoxysilanehe obtained modified materials were investigated as matrixes for the anticancer drug (gemcitabine) delivery. The prepared samples were characterized by SAXS, N2 adsorption/desorption, SEM, transmission electron microscopy, thermogravimetric analysis, and FTIR and UV spectroscopies. The adsorption and release properties of all samples were studied. It was revealed that the adsorption capacity and release behavior of gemcitabine were highly dependent on the type of the introduced functional groups. The carboxylic acid-modified samples have higher loading content, due to the strong interaction with gemcitabine. The maximum content of deposited drug in the modified SBA-15 nanorods is close to 40 wt%. It was found that the surface functionalization leads toward significant decrease of the drug release rate. The carboxylic acid-functionalized samples have slower release rate in contrast with the amino-functionalized samples.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Andersson J, Rosenholm J, Areva S, Lindén M (2004) Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 16(21):4160–416710.1021/cm0401490 ↗
2. Badiei A, Goldooz H, Ziarani GM (2011) A novel method for preparation of 8-hydroxyquinoline functionalized mesoporous silica: aluminum complexes and photoluminescence studies. Appl Surf Sci 257(11):4912–491810.1016/j.apsusc.2010.12.146 ↗
3. Bahrami Z, Badiei A, Atyabi F (2014) Surface functionalization of SBA-15 nanorods for anticancer drug delivery. Chem Eng Res Des 92:1296–130310.1016/j.cherd.2013.11.007 ↗
4. Barbé C, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug-delivery system. Adv Mater 16:1949–196610.1002/adma.200400771 ↗
5. Braakhuis BJ, Dongen GAV, Vermorken JB, Snow GB (1991) Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer. Cancer Res 51:211–214
6. Burris H, Storniolo AM (1997) Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer 33:S18–S2210.1016/S0959-8049(96)00324-3 ↗
7. Cariono IS, Pasqua L, Testa F, Aiello R, Puoci F, Iemma F, Picci N (2007) Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 14:491–49510.1080/10717540701606244 ↗
8. Cauda V, Schlossbauer A, Bein T (2010) Bio-degradation study of colloidal mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes and poly (ethylene glycol). Microporous Mesoporous Mater 132(1–2):60–7110.1016/j.micromeso.2009.11.015 ↗
9. Fan J, Lei J, Wang L, Yu C, Tu B, Zhao D (2003) Rapid and high-capacity immobilization of enzymes based on mesoporous silicas with controlled morphologies. Chem Commun 17:2140–214110.1039/b304391f ↗
10. Halamová D, Badaničová M, Zeleňák V, Gondová T, Vainio U (2010) Naproxen drug delivery using periodic mesoporous silica SBA-15. Appl Surf Sci 256(22):6489–649410.1016/j.apsusc.2010.04.044 ↗
11. Horcajada P, Rámila A, Pérez-Pariente J, Vallet Regı M (2004) Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 68(1–3):105–10910.1016/j.micromeso.2003.12.012 ↗
12. Horcajada P, Rámila A, Férey G, Vallet-Regí M (2006) Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci 8(10):1243–124910.1016/j.solidstatesciences.2006.04.016 ↗
13. Izquierdo-Barba I, Sanchez-Salcedo S, Colilla M, Feito MJ, Ramirez-Santillan C, Portoles MT, Vallet-Regi M (2011) Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomater 7(7):2977–298510.1016/j.actbio.2011.03.005 ↗
14. Jaroniec CP, Kruk M, Jaroniec M, Sayari A (1998) Tailoring surface and structural properties of MCM-41 silicas by bonding organosilanes. J Phys Chem B 102(28):5503–551010.1021/jp981304z ↗
15. Khaniani Y, Badiei A, Mohammadi Ziarani G (2012) Application of clickable nanoporous silica surface for immobilization of ionic liquids. J Mater Res 27(6):932–93810.1557/jmr.2011.435 ↗
16. Lee HI, Kim JH, Stucky GD, Shi Y, Pak C, Kim JM (2010) Morphology-selective synthesis of mesoporous SBA-15 particles over micrometer, submicrometer and nanometer scales. J Mater Chem 20(39):8483–848710.1039/c0jm00820f ↗
17. Lei J, Fan J, Yu C, Zhang L, Jiang S, Tu B, Zhao D (2004) Immobilization of enzymes in mesoporous materials: controlling the entrance to nanospace. Microporous Mesoporous Mater 73(3):121–12810.1016/j.micromeso.2004.05.004 ↗
18. Lu J, Liong M, Zink JI, Fuyuhiko T (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3(8):1341–134610.1002/smll.200700005 ↗
19. Moritz M, Łaniecki M (2012) SBA-15 mesoporous material modified with APTES as the carrier for 2-(3-benzoylphenyl)propionic acid. Appl Surf Sci 258(19):7523–752910.1016/j.apsusc.2012.04.076 ↗
20. Munoz B, Ramila A, Perez-Pariente J, Dıaz I, Vallet-Regı M (2003) MCM-41 organic modification as drug delivery rate regulator. Chem Mater 15:500–50310.1021/cm021217q ↗
21. Ng JBS, Kamali-Zare P, Brismar H, Bergström L (2008) Release and molecular transport of cationic and anionic fluorescent molecules in mesoporous silica spheres. Langmuir 24(19):11096–1110210.1021/la801179v ↗
22. Nieto A, Balas F, Colilla M, Manzano M, Vallet-Regí M (2008) Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater 116(1–3):4–1310.1016/j.micromeso.2008.03.025 ↗
23. Nunes CD, Vaz PD, Fernandes AC, Ferreira P, Romäo CC, Calhordo MJ (2007) Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm 66:357–36510.1016/j.ejpb.2006.11.023 ↗
24. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P (2010) Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 62:346–36110.1016/j.addr.2009.11.007 ↗
25. Popova MD, Szegedi A, Kolev IN, Mihaly J, Tzankov BS, Momekov GT, Lambov NG, Yoncheva KP (2012) Carboxylic modified spherical mesoporous silicas small a, Cyrillics drug delivery carriers. Int J Pharm 436(1–2):778–78510.1016/j.ijpharm.2012.07.061 ↗
26. Prokopowicz M, Przyjazny A (2007) Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin. J Microencapsul 24:694–71310.1080/02652040701547658 ↗
27. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, Qiu S (2006) Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater 92(1–3):1–910.1016/j.micromeso.2005.12.004 ↗
28. Sevimli F, Yılmaz A (2012) Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater 158:281–29110.1016/j.micromeso.2012.02.037 ↗
29. Shen SC, Ng WK, Chia L, Hu J, Tan RB (2011) Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm 410(1–2):188–19510.1016/j.ijpharm.2011.03.018 ↗
30. Socrates G (2004) Infrared and Raman Characteristic group frequencies: tables and charts. Wiley, Chichester
31. Song SW, Hidajat K, Kawi S (2005) Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix−drug interactions. Langmuir 21(21):9568–957510.1021/la051167e ↗
32. Strømme M, Brohede U, Atluri R, Garcia-Bennett AE (2009) Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Nanomed Nanobiotech 1(1):140–14810.1002/wnan.13 ↗
33. Szegedi A, Popova M, Goshev I, Mihály J (2011) Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release. J Solid State Chem 184:1201–120710.1016/j.jssc.2011.03.005 ↗
34. Tang Q, Xu Y, Wu D, Sun Y (2006) A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J Solid State Chem 179(5):1513–152010.1016/j.jssc.2006.02.004 ↗
35. Tourné-Péteilh C, Lerner DA, Charnay C, Nicole L, Begu S, Devoisselle JM (2003) The potential of ordered mesoporous silica for the storage of drugs: the example of a pentapeptide encapsulated in aMSU-Tween 80. Chem Phys Chem 4:281–28610.1002/cphc.200390045 ↗
36. Tozuka Y, Sugiyama E, Takeuchi H (2010) Release profile of insulin entrapped on mesoporous materials by freeze-thaw method. Int J Pharm 386:172–17710.1016/j.ijpharm.2009.11.012 ↗
37. Tsai CP, Hung Y, Chou YH, Huang DM, Hsiao JK, Chang C, Chen YC, Mou CY (2008) High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 4(2):186–19110.1002/smll.200700457 ↗
38. Vallet-Regí M, Ruiz-González L, Izquierdo-Barba I, Gonzalez-Callbet JM (2006) Revisiting silica based ordered mesoporous materials: medical application. J Mater Chem 16:26–3110.1039/B509744D ↗
39. Yadavi M, Badiei A, Mohammadi Ziarani G (2013) A novel Fe3+ions chemosensor by covalent coupling fluorene onto the mono, di- and tri-ammonium functionalized nanoporous silica type SBA-15. Appl Surf Sci 279:121–12810.1016/j.apsusc.2013.04.048 ↗
40. Yang LM, Wang YJ, Luo GS, Dai YY (2005a) Functionalization of SBA-15 mesoporous silica with thiol or sulfonic acid groups under the crystallization conditions. Microporous Mesoporous Mater 84(1–3):275–28210.1016/j.micromeso.2005.05.037 ↗
41. Yang Q, Wang S, Fan P, Wang L, Di Y, Lin K, Xiao FS (2005b) pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mater 17(24):5999–600310.1021/cm051198v ↗
42. Yuan L, Tang Q, Yang D, Zhang JZ, Zhang F, Hu J (2011) Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C 115(20):9926–993210.1021/jp201053d ↗
43. Zeng W, Qian XF, Zhang YB, Yin J, Zhu ZK (2005) Organic modified mesoporous MCM-41 through solvothermal process as drug delivery system. Mater Res Bull 40(5):766–77210.1016/j.materresbull.2005.02.011 ↗
44. Zhuravlev LT (2000) The surface chemistry of amorphous silica. Zhuravlev model. Colloids Surf A 173(1–3):1–3810.1016/S0927-7757(00)00556-2 ↗